Investigational Pentavalent Meningococcal Vaccine Safe, Noninferior To Licensed Quadrivalent Vaccine, Trial Suggests
May 25, 2023
MedPage Today (5/24, Short) reports, “In a randomized trial conducted in the African meningitis belt, an investigational pentavalent meningococcal vaccine proved safe and with noninferior immunogenicity to a licensed quadrivalent product, likely paving th...